DiaSorin offers the cardiac markers line on LIAISON® systems.
LIAISON® CKMB is an in vitro assay for the quantitative determination of mass creatine phosphokinase MB isoform (CKMB) in serum and plasma. LIAISON® CKMB is designed for test performance on the fully automated LIAISON® Analyzer.
In vitro assay for the quantitative determination of myoglobin in human serum as well as in human plasma (citrated/EDTA). The test has to be performed on the LIAISON® Analyzer.
In vitro assay for the quantitative determination of cardiac troponin I (cTnI) in human serum as well as in EDTA and heparinised human plasma. The test has to be performed on the LIAISON® Analyzer.
Cardiac markers are proteins expressed commonly or exclusively by myocardial cells and released into the circulating blood upon cell necrosis. They are known as troponin I, myoglobin and CK-MB.
These cardiac markers play an essential role in the global risk assessment and treatment of patients presenting with an acute coronary syndrome (ACS).